Gpt Healthcare Ltd vs Nephro Care India Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 31, 2026

Key Highlights

The Latest Trading Price of GPT Healthcare Ltd is ₹ 132.7 as of 30 Oct 15:30 . The P/E Ratio of GPT Healthcare Ltd is 0 as of March 2021 .The P/E Ratio of Nephro Care India Ltd is 0 as of March 2021 . The Market Cap of GPT Healthcare Ltd is ₹ 0 crore as of March 2021 .The Market Cap of Nephro Care India Ltd is ₹ 0 crore as of March 2021 . The Revenue of GPT Healthcare Ltd is ₹ 0 crore as of Jun '25 .The Revenue of Nephro Care India Ltd is ₹ 17.39 crore as of Jun '25 . The EBITDA of GPT Healthcare Ltd is ₹ 0 crore as of Jun '25 .The EBITDA of Nephro Care India Ltd is ₹ 0.66 crore as of Jun '25 . The Net Profit of GPT Healthcare Ltd is ₹ 0 crore as of Jun '25 .The Net Profit of Nephro Care India Ltd is ₹ -0.65 crore as of Jun '25 . The Dividend Payout of GPT Healthcare Ltd changed from 46.79 % on March 2021 to 48.58 % on March 2026 . This represents a CAGR of 0.63% over 6 yearsThe Dividend Payout of Nephro Care India Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About GPT Healthcare Ltd

GPT Healthcare Limited was formerly established as 'Jibansatya Printing House Private Limited' on August 17, 1989 at Kolkata, West Bengal.
The name of Company was changed to 'GPT Healthcare Private Limited' by the Registrar of Companies on March 31, 2005.
Thereafter, Company converted to a Public Company and the name was changed to 'GPT Healthcare Limited'.
Consequent upon change in name to a Limited Company, a fresh Certificate of Incorporation was issued by the RoC on September 15, 2021. The principal activities of the Company include operation of multidisciplinary private hospitals and pharmacies.
The Company is having four Multispecialty hospitals.

About Nephro Care India Ltd

Nephro Care India Limited was originally incorporated on July 08, 2014 as a Private Limited Company as 'Nephro Care India Private Limited' with the Registrar of Companies, West Bengal.
Subsequently, Company converted into a Public Limited Company and the name of Company was changed to Nephro Care India Limited' and a fresh Certificate of Incorporation dated March 5, 2024, was issued by the Registrar of Companies, Central Processing Centre. Nephro Care was founded in the year 2014 by Dr. Pratim Sengupta in Kolkata with an object of providing comprehensive medical services for renal patients.
The Company is a one stop treatment centre based in Kolkata that offer clinical and lifestyle solutions and services and renal insufficiency treatment to patients.
The treatment framework covers the entire range of lifestyle, physiological and spiritual aspects of wellness.

FAQs for the comparison of GPT Healthcare Ltd and Nephro Care India Ltd

Which company has a larger market capitalization, GPT Healthcare Ltd or Nephro Care India Ltd?

Market cap of GPT Healthcare Ltd is 1,088 Cr while Market cap of Nephro Care India Ltd is 134 Cr

What are the key factors driving the stock performance of GPT Healthcare Ltd and Nephro Care India Ltd?

The stock performance of GPT Healthcare Ltd and Nephro Care India Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for GPT Healthcare Ltd and Nephro Care India Ltd?

As of October 31, 2026, the GPT Healthcare Ltd stock price is INR ₹132.7. On the other hand, Nephro Care India Ltd stock price is INR ₹81.3.

How do dividend payouts of GPT Healthcare Ltd and Nephro Care India Ltd compare?

To compare the dividend payouts of GPT Healthcare Ltd and Nephro Care India Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.